Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy

Objective: To identify cryptic chromosomal deletions involving SCN1A in patients with severe myoclonic epilepsy of infancy (SMEI). Methods: Thirty-nine patients with SMEI and without SCN1A point mutations and their parents were typed with 14 intragenic SCN1A polymorphisms to identify hemizygosity. The parental origin and the extent of genomic deletions were determined by fluorescence in situ hybridization analysis using genomic clones encompassing chromosome 2q24.3-q31.1. Deletion breakpoints were more finely mapped by typing single-nucleotide polymorphisms and microsatellite markers. Results: We identified three patients with SMEI who had genomic deletions encompassing the SCN1A locus. Deletion size was between 607 kb and 4.7 Mb. Deletions originated de novo from paternal chromosome in all subjects. One patient had central precocious puberty and palatoschisis. Genotype–phenotype correlations suggest that these clinical features are due to genes centromeric to SCN1A. Conclusions: Patients with severe myoclonic epilepsy of infancy (SMEI) lacking SCN1A point mutations should be investigated for cryptic chromosomal deletions involving SCN1A. Clinical features other than epilepsy could be associated with SMEI as a consequence of deletions in contiguous genes.

[1]  C. van Broeckhoven,et al.  Genes and loci involved in febrile seizures and related epilepsy syndromes , 2006, Human mutation.

[2]  A. M. Rush,et al.  Sporadic onset of erythermalgia: A gain‐of‐function mutation in Nav1.7 , 2006, Annals of neurology.

[3]  F. Zara,et al.  Multiplex real-time PCR for detection of deletions and duplications in dystrophin gene. , 2006, Biochemical and biophysical research communications.

[4]  K. Yamakawa,et al.  A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures , 2005, Brain and Development.

[5]  S. Dib-Hajj,et al.  Erythromelalgia: A hereditary pain syndrome enters the molecular era , 2005, Annals of neurology.

[6]  Carlos G Vanoye,et al.  Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Genton,et al.  Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A , 2004, Neurology.

[8]  G. Taylor,et al.  MLPA and MAPH: New techniques for detection of gene deletions , 2004, Human mutation.

[9]  I. Scheffer,et al.  Benign familial neonatal‐infantile seizures: Characterization of a new sodium channelopathy , 2004, Annals of neurology.

[10]  K. Yamakawa,et al.  A Nonsense Mutation of the Sodium Channel Gene SCN2A in a Patient with Intractable Epilepsy and Mental Decline , 2004, The Journal of Neuroscience.

[11]  F. Besag.  Behavioral aspects of pediatric epilepsy syndromes , 2004, Epilepsy & Behavior.

[12]  O. Devinsky,et al.  Epilepsy-Associated Dysfunction in the Voltage-Gated Neuronal Sodium Channel SCN1A , 2003, The Journal of Neuroscience.

[13]  J. Klingensmith,et al.  Cordon-bleu is a conserved gene involved in neural tube formation. , 2003, Developmental biology.

[14]  E. Bertini,et al.  Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy , 2003, Neurology.

[15]  M. Didi,et al.  Cranial MRI scans are indicated in all girls with central precocious puberty , 2003, Archives of disease in childhood.

[16]  K. Yamakawa,et al.  Nav1.1 channels with mutations of severe myoclonic epilepsy in infancy display attenuated currents , 2003, Epilepsy Research.

[17]  A. Sano,et al.  Role of Na+ and Ca2+ channels in the preoptic LH surge generating mechanism in proestrous rats. , 2003, Endocrine journal.

[18]  M. Noda,et al.  Nax channel involved in CNS sodium-level sensing , 2002, Nature Neuroscience.

[19]  M. Depew,et al.  Mouse Development: Patterning, Morphogenesis, and Organogenesis , 2002 .

[20]  L. Lagae,et al.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. , 2001, American journal of human genetics.

[21]  M. Noda,et al.  Nav2/NaG Channel Is Involved in Control of Salt-Intake Behavior in the CNS , 2000, The Journal of Neuroscience.

[22]  M. Batzer,et al.  Alu repeats and human disease. , 1999, Molecular genetics and metabolism.

[23]  K. Mogi,et al.  Pulsatile release of luteinizing hormone-releasing hormone (LHRH) in cultured LHRH neurons derived from the embryonic olfactory placode of the rhesus monkey. , 1999, Endocrinology.

[24]  S. Olson,et al.  Clinical outcomes of four patients with microdeletion in the long arm of chromosome 2. , 1998, American journal of medical genetics.

[25]  S. Tobet,et al.  Gonadotropin-Releasing Hormone Containing Neurons and Olfactory Fibers During Development: From Lamprey to Mammals , 1997, Brain Research Bulletin.

[26]  R. Boles,et al.  Deletion of chromosome 2q24-q31 causes characteristic digital anomalies: case report and review. , 1995, American journal of medical genetics.

[27]  M. Schmid,et al.  Interstitial deletion del(2)(q24q31) with a phenotype similar to del(2)(q31q33). , 1991, American journal of medical genetics.

[28]  H. Oguni,et al.  Severe myoclonic epilepsy in infancy: Dravet syndrome. , 2005, Advances in neurology.

[29]  P. Lichter,et al.  Chromosome analysis by non-isotopic in situ hybridization. , 1992 .